Search research articles
Contact Us
Filters
Showing results (1-10 of 76) with videos related to
Page
of 8
Sort By:
The Patient
|
January 15, 2018
Evaluating Risk Tolerance from a Systematic Review of Preferences: The Case of Patients with Psoriasis
Juan Marcos Gonzalez
The Patient
|
March 26, 2019
A Guide to Measuring and Interpreting Attribute Importance
Juan Marcos Gonzalez
The Patient
|
May 7, 2021
The Impact of the Risk Functional Form Assumptions on Maximum Acceptable Risk Measures
Juan Marcos Gonzalez, Marco Boeri
Palliative Medicine
|
October 7, 2025
Palliative care experts' relative importance of end-of-life care quality indicators: Findings from a discrete choice experiment
Eric Andrew Finkelstein, Juan Marcos Gonzalez Sepulveda
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 31, 2020
Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study
Shelby Reed, Juan Marcos Gonzalez, F Reed Johnson
The American Journal of Gastroenterology
|
July 4, 2018
Letter to the Editor Regarding Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis
Reed F Johnson, Shelby Reed, Juan Marcos Gonzalez
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
November 3, 2022
Method for Calculating the Simultaneous Maximum Acceptable Risk Threshold (SMART) from Discrete-Choice Experiment Benefit-Risk Studies
Angelyn Otteson Fairchild, Shelby D Reed, Juan Marcos Gonzalez
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 5, 2026
What is the Consensus Value of Patients' Treatment-Risk Tolerance? Assessing a Stated-Preference Evidence Base for Inflammatory Bowel Disease
F Reed Johnson, Juan Marcos Gonzalez, Jui-Chen Yang
Blood Advances
|
July 10, 2024
The critical role of symptom experience on risk tolerance for gene therapy
Juan Marcos Gonzalez Sepulveda, Shelby D Reed, Marilyn Telen
Frontiers in Immunology
|
February 21, 2022
Primary Immune Deficiency: Patients' Preferences for Replacement Immunoglobulin Therapy
Juan Marcos Gonzalez, Mark Ballow, Angelyn Fairchild, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 76) with videos related to
Sort By:
Page
of 8
The Patient
|
January 15, 2018
Evaluating Risk Tolerance from a Systematic Review of Preferences: The Case of Patients with Psoriasis
Juan Marcos Gonzalez
The Patient
|
March 26, 2019
A Guide to Measuring and Interpreting Attribute Importance
Juan Marcos Gonzalez
The Patient
|
May 7, 2021
The Impact of the Risk Functional Form Assumptions on Maximum Acceptable Risk Measures
Juan Marcos Gonzalez, Marco Boeri
Palliative Medicine
|
October 7, 2025
Palliative care experts' relative importance of end-of-life care quality indicators: Findings from a discrete choice experiment
Eric Andrew Finkelstein, Juan Marcos Gonzalez Sepulveda
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 31, 2020
Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study
Shelby Reed, Juan Marcos Gonzalez, F Reed Johnson
The American Journal of Gastroenterology
|
July 4, 2018
Letter to the Editor Regarding Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis
Reed F Johnson, Shelby Reed, Juan Marcos Gonzalez
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
November 3, 2022
Method for Calculating the Simultaneous Maximum Acceptable Risk Threshold (SMART) from Discrete-Choice Experiment Benefit-Risk Studies
Angelyn Otteson Fairchild, Shelby D Reed, Juan Marcos Gonzalez
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 5, 2026
What is the Consensus Value of Patients' Treatment-Risk Tolerance? Assessing a Stated-Preference Evidence Base for Inflammatory Bowel Disease
F Reed Johnson, Juan Marcos Gonzalez, Jui-Chen Yang
Blood Advances
|
July 10, 2024
The critical role of symptom experience on risk tolerance for gene therapy
Juan Marcos Gonzalez Sepulveda, Shelby D Reed, Marilyn Telen
Frontiers in Immunology
|
February 21, 2022
Primary Immune Deficiency: Patients' Preferences for Replacement Immunoglobulin Therapy
Juan Marcos Gonzalez, Mark Ballow, Angelyn Fairchild, et al.
Page
of 8